Galderma SA:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Galderma SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3317
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Galderma SA (Galderma), a subsidiary of Nestle SA, is a pharmaceutical company that develops and markets drugs, medical dermatology solutions and therapeutic skin care products for the treatment of hair, nail, and skin diseases. Galderma offers products for the treatment of skin conditions such as seborrheic dermatitis, dry skin, acne, psoriasis, atopic dermatitis, steroid responsive dermatoses, pigmentation disorders, aging skin, onychomycosis, rosacea, skin cancer and others. The company offers products leading brands such as Azzalure, Cetaphil, Clobex, Macrolane, and Oracea among several others. It markets products in India, Greece, Italy, Canada, Chile, Poland, the UK, and the US, among others. The company operates manufacturing facilities in France, Sweden, Canada, Brazil, Germany and Switzerland and research and development (R&D) centers in France, Sweden, the US, Switzerland and Japan. Galderma is headquartered in Lausanne, Switzerland.

Galderma SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Galderma SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Galderma SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Galderma SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Galderma SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Galderma SA, Medical Devices Deals, 2012 to YTD 2018 9
Galderma SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Galderma SA, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Galderma to Acquire Assets of Laboratoires Inneov from L’Oreal 11
Galderma Completes Acquisition of Aesthetic Dermatology Assets from Valeant Pharma for USD1.4 Billion 12
Galderma Acquires Pekiron Cream From Kyorin Pharma 13
Partnerships 14
Galderma Enters into Research Agreement with Icahn School of Medicine at Mount Sinai and Northwestern University Feinberg School of Medicine 14
Bioventus Enters into Agreement with Galderma for Durolane in US 15
Galderma Enters into Distribution Agreement with Ipsen for Dysport in Asia-Pacific 16
Galderma Enters into Agreement with ZELTIQ Aesthetics 17
Galderma Enters into Agreement with ImaBiotech 18
Ipsen Extends Distribution Agreement with Galderma for Dysport 19
Ipsen Extends Distribution Agreement With Galderma For Dysport 21
Sinclair IS Pharma Enters Into Co-Promotion Agreement With Galderma For Kelo-cote 22
Licensing Agreements 23
Clementia Pharma Enters into Licensing Agreement with Galderma R&D 23
Galderma Pharma Enters into Licensing Agreement with Chugai Pharma 24
Nuvo Research Enters into Licensing Agreement with Galderma Pharma for Pliaglis 25
Asset Transactions 26
Bioventus Acquires Durolane Assets From Galderma 26
Onset Dermatologics Acquires Worldwide Rights To Clindagel From Galderma Labs 27
STADA Arzneimittel Completes Acquisition Of Generics Business From Spirig Pharma For US$108 Million 28
Acquisition 29
Nestle Completes Acquisition of Remaining 50% Stake in Galderma for USD3.5 Billion 29
Galderma Pharma Acquires Spirig Pharma 30
Galderma SA – Key Competitors 31
Galderma SA – Key Employees 32
Galderma SA – Locations And Subsidiaries 33
Head Office 33
Other Locations & Subsidiaries 33
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36

List of Tables
Galderma SA, Pharmaceuticals & Healthcare, Key Facts 2
Galderma SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Galderma SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Galderma SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Galderma SA, Deals By Therapy Area, 2012 to YTD 2018 8
Galderma SA, Medical Devices Deals, 2012 to YTD 2018 9
Galderma SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Galderma to Acquire Assets of Laboratoires Inneov from L'Oreal 11
Galderma Completes Acquisition of Aesthetic Dermatology Assets from Valeant Pharma for USD1.4 Billion 12
Galderma Acquires Pekiron Cream From Kyorin Pharma 13
Galderma Enters into Research Agreement with Icahn School of Medicine at Mount Sinai and Northwestern University Feinberg School of Medicine 14
Bioventus Enters into Agreement with Galderma for Durolane in US 15
Galderma Enters into Distribution Agreement with Ipsen for Dysport in Asia-Pacific 16
Galderma Enters into Agreement with ZELTIQ Aesthetics 17
Galderma Enters into Agreement with ImaBiotech 18
Ipsen Extends Distribution Agreement with Galderma for Dysport 19
Ipsen Extends Distribution Agreement With Galderma For Dysport 21
Sinclair IS Pharma Enters Into Co-Promotion Agreement With Galderma For Kelo-cote 22
Clementia Pharma Enters into Licensing Agreement with Galderma R&D 23
Galderma Pharma Enters into Licensing Agreement with Chugai Pharma 24
Nuvo Research Enters into Licensing Agreement with Galderma Pharma for Pliaglis 25
Bioventus Acquires Durolane Assets From Galderma 26
Onset Dermatologics Acquires Worldwide Rights To Clindagel From Galderma Labs 27
STADA Arzneimittel Completes Acquisition Of Generics Business From Spirig Pharma For US$108 Million 28
Nestle Completes Acquisition of Remaining 50% Stake in Galderma for USD3.5 Billion 29
Galderma Pharma Acquires Spirig Pharma 30
Galderma SA, Key Competitors 31
Galderma SA, Key Employees 32
Galderma SA, Other Locations 33
Galderma SA, Subsidiaries 33

List of Figures
Galderma SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Galderma SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Galderma SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Galderma SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Galderma SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Galderma SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Galderma SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Galderma SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Galderma SA, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Galderma SA:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sterling Energy plc (SEY):企業の財務・戦略的SWOT分析
    Summary Sterling Energy Plc (Sterling) is an oil and gas company that offers oil and gas exploration and development services. The company acquires, produces, operates, manages, and develops crude oil and natural gas producing assets. It operates and manages oil and gas exploration projects such as …
  • Global Franchise Group, LLC:企業の戦略・SWOT・財務情報
    Global Franchise Group, LLC - Strategy, SWOT and Corporate Finance Report Summary Global Franchise Group, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Hycor Biomedical Inc-医療機器分野:企業M&A・提携分析
    Summary Hycor Biomedical Inc (Hycor) is a medical device company that manufactures and markets in-vitro diagnostic products. The company offers products such as auto immune testing systems, allergy testing systems, HYTEC plus and HYCOR ultrasensitive EIA products. Its auto immune testing products co …
  • Unique Catering & Management Services Ltd:企業の戦略・SWOT・財務情報
    Unique Catering & Management Services Ltd - Strategy, SWOT and Corporate Finance Report Summary Unique Catering & Management Services Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Kenon Holdings Ltd (KEN):企業の財務・戦略的SWOT分析
    Kenon Holdings Ltd (KEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Caldera Health Ltd:企業の製品パイプライン分析2018
    Summary Caldera Health Ltd (Caldera) is a biotech company that develops prostate cancer diagnostic tools. The company offers prostate cancer diagnostic and prognostic tests to detect and monitor the cancer disease. It has developed a laboratory test that measures the expression of a range of RNA bio …
  • Massachusetts Institute of Technology-製薬・医療分野:企業M&A・提携分析
    Summary Massachusetts Institute of Technology (MIT) is a research university that provides contract research and education. The institute offers education in the areas of computer science, biology, aeronautics, mechanical engineering, civil engineering, economics, electrical engineering, literature, …
  • Europlasma SA (ALEUP):電力:M&Aディール及び事業提携情報
    Summary Europlasma SA (Europlasma) is a leading provider of clean technology and renewable energy solutions in Europe. The company along with its group companies offers plasma solutions to treat gas and hazardous waste and conducts waste disposal and power production from waste and biomass and recyc …
  • RCS MediaGroup S.p.A. (RCS):企業の財務・戦略的SWOT分析
    RCS MediaGroup S.p.A. (RCS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Novosibirsk International Airport (Tolmachevo):企業の戦略・SWOT・財務情報
    Novosibirsk International Airport (Tolmachevo) - Strategy, SWOT and Corporate Finance Report Summary Novosibirsk International Airport (Tolmachevo) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • CP Kelco:企業の戦略・SWOT・財務情報
    CP Kelco - Strategy, SWOT and Corporate Finance Report Summary CP Kelco - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Prudential Plc:戦略・SWOT・企業財務分析
    Prudential Plc - Strategy, SWOT and Corporate Finance Report Summary Prudential Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Odonate Therapeutics LLC-製薬・医療分野:企業M&A・提携分析
    Summary Odonate Therapeutics LLC (Odonate) is a company that develops medicines for the treatment of cancer. It develops best in class medicines that enhance and extend the lives of patients suffering from cancer. Odonate’s lead product candidate, tesetaxel, is a novel orally administered taxane use …
  • National Fuel Gas Co (NFG):企業の財務・戦略的SWOT分析
    National Fuel Gas Co (NFG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • InCarda Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary InCarda Therapeutics Inc (InCarda) is a biopharmaceutical company that concentrates on the development of transformative therapies for cardiovascular conditions through the inhalation route. The company’s lead product candidate includes InRhythm, an inhaled antiarrhythmic for acute treatment …
  • Arsenal Holdings PLC:企業の戦略的SWOT分析
    Arsenal Holdings PLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Ivanhoe Mines Ltd:企業のM&A・事業提携・投資動向
    Ivanhoe Mines Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ivanhoe Mines Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Marathon Pharmaceuticals LLC-製薬・医療分野:企業M&A・提携分析
    Summary Marathon Pharmaceuticals LLC (Marathon Pharmaceuticals) focuses on the development, manufacturing and commercialization of treatments for rare neurological and movement disorders. It develops products in various therapeutic areas which include duchenne muscular dystrophy, pediatric juvenile …
  • Metlifecare Ltd (MET):企業の財務・戦略的SWOT分析
    Metlifecare Ltd (MET) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • BlueScope Steel Ltd:企業のM&A・事業提携・投資動向
    BlueScope Steel Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's BlueScope Steel Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆